SLP:NASDAQ
Simulations Plus Inc
$18.50
0.00%
(0.00) 1D
Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLP...
Mkt. cap
374.16M
Avg. vol.
229.34K
Volume
0.00
P/E ratio
46.22
52-wk high
$21.01
52-wk low
$11.09
EPS
$0.40
Beta
1.31
Shares outstanding
20.22M
No. of employees
213
Mkt. cap
374.16M
Avg. vol.
229.34K
Volume
0.00
P/E ratio
46.22
52-wk high
$21.01
52-wk low
$11.09
EPS
$0.40
Beta
1.31
Shares outstanding
20.22M
No. of employees
213
News stories
From web sources and news partners
www.marketscreener.com
·
1 day ago
Simulations Plus, Inc. Announces Funded Partnership With Global Pharmaceutical Company To Advance AI-Enabled QSP Model Development With Turin
Stock Titan
·
1 day ago
A drugmaker will test whether AI can help scientists build models of how diseases work faster.
www.marketscreener.com
·
4 days ago
Simulations Plus Stock (SLP) - Quote Nasdaq
Profile
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. Wikipedia
About Simulations Plus Inc
CEO-
Employees213
Founded1996
HeadquartersLancaster, California, United States
SectorHealth care
Websitesimulations-plus.com